A detailed history of Truist Financial Corp transactions in Moderna, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 11,485 shares of MRNA stock, worth $440,564. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,485
Previous 18,657 38.44%
Holding current value
$440,564
Previous $2.22 Million 65.37%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$63.64 - $125.14 $456,426 - $897,504
-7,172 Reduced 38.44%
11,485 $767,000
Q2 2024

Aug 20, 2024

BUY
$101.21 - $166.61 $129,042 - $212,427
1,275 Added 7.34%
18,657 $2.22 Million
Q1 2024

May 10, 2024

SELL
$85.37 - $115.44 $199,082 - $269,206
-2,332 Reduced 11.83%
17,382 $1.85 Million
Q4 2023

Feb 02, 2024

SELL
$69.51 - $104.43 $10,843 - $16,291
-156 Reduced 0.79%
19,714 $1.96 Million
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $1.13 Million - $1.48 Million
11,718 Added 143.74%
19,870 $2.05 Million
Q2 2023

Aug 01, 2023

BUY
$118.5 - $160.53 $109,731 - $148,650
926 Added 12.81%
8,152 $990,000
Q1 2023

May 05, 2023

SELL
$135.66 - $197.02 $215,835 - $313,458
-1,591 Reduced 18.04%
7,226 $1.11 Million
Q4 2022

Feb 17, 2023

BUY
$118.38 - $210.04 $263,395 - $467,339
2,225 Added 33.75%
8,817 $1.58 Million
Q3 2022

Oct 26, 2022

BUY
$118.07 - $194.18 $36,129 - $59,419
306 Added 4.87%
6,592 $779,000
Q2 2022

Jul 22, 2022

SELL
$117.13 - $176.59 $93,938 - $141,625
-802 Reduced 11.31%
6,286 $899,000
Q1 2022

Apr 22, 2022

SELL
$126.46 - $235.05 $4.21 Million - $7.82 Million
-33,285 Reduced 82.44%
7,088 $1.22 Million
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $842,534 - $1.37 Million
-3,731 Reduced 8.46%
40,373 $10.3 Million
Q3 2021

Nov 05, 2021

SELL
$221.9 - $484.47 $2.38 Million - $5.2 Million
-10,738 Reduced 19.58%
44,104 $17 Million
Q2 2021

Aug 16, 2021

SELL
$129.91 - $234.98 $1.06 Million - $1.91 Million
-8,131 Reduced 12.91%
54,842 $12.9 Million
Q1 2021

May 17, 2021

BUY
$109.18 - $185.98 $1.52 Million - $2.59 Million
13,934 Added 28.41%
62,973 $8.25 Million
Q4 2020

Nov 19, 2021

SELL
$65.74 - $169.86 $679,948 - $1.76 Million
-10,343 Reduced 17.42%
49,039 $5.12 Million
Q4 2020

Feb 18, 2021

BUY
$65.74 - $169.86 $1.86 Million - $4.8 Million
28,270 Added 90.87%
59,382 $6.2 Million
Q3 2020

Nov 13, 2020

BUY
$54.34 - $94.85 $1.43 Million - $2.5 Million
26,330 Added 550.61%
31,112 $2.2 Million
Q2 2020

Aug 14, 2020

BUY
$29.67 - $80.0 $141,881 - $382,560
4,782 New
4,782 $307,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.